Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Daniel Brás
Observed names:
Brás, Daniel,
D Bras,
D. Bras,
D. Brás,
D.B. Daniel Brás,
Daniel Bras
show all 6
Institutions:
Comprehensive Health Research Centre,
Universidade Nova de Lisboa
Observed institutions:
Hospital de São João,
Novartis Farma SA (Portugal),
Comprehensive Health Research Centre,
Universidade Nova de Lisboa
ORCID:
0000-0002-0598-3013
Observed ORCID:
0000-0002-0598-3013
OpenAlex ID:
A5046258091
Insuficiência cardíaca em números: estimativas para o século XXI em Portugal
2018
·
Cândida Fonseca
, Daniel Brás
, et al.
·
Revista Portuguesa de Cardiologia
·
88
Heart failure in numbers: Estimates for the 21st century in Portugal
2018
·
Cândida Fonseca
, Daniel Brás
, et al.
·
Revista Portuguesa de Cardiologia (English Edition)
·
39
PDF
A closer look at acute heart failure: Putting Portuguese and European data into perspective
2016
·
Cândida Fonseca
, Inês Araújo
, et al.
·
Revista Portuguesa de Cardiologia
·
18
PDF
Neurohormonal modulation: The new paradigm of pharmacological treatment of heart failure
2019
·
J. Silva-Cardoso
, D. Brás
, et al.
·
Revista Portuguesa de Cardiologia
·
9
PDF
Real-World Clinical Characterisation of Polycythaemia Vera Patients from a Prospective Registry in Portugal: Is Resistance to Hydroxyurea a Reality?
2023
·
Maria Sarmento
, Marta Duarte
, et al.
·
Hematology Reports
·
6
PDF
A systematic review of in-hospital worsening heart failure as an endpoint in clinical investigations of therapy for acute heart failure
2017
·
Cândida Fonseca
, Aldo Pietro Maggioni
, et al.
·
International Journal of Cardiology
·
5
P1484: Understanding Stakeholders’ Knowledge on Sickle Cell Disease and Their Perception on the Patient Journey by Social Media Listening Across Europe
2022
·
D. Bras
, C. Bento
, et al.
·
HemaSphere
·
1
Erratum to “A systematic review of in-hospital worsening heart failure as an endpoint in clinical investigations of therapy for acute heart failure” [Int. J. Cardiol. 250 (2018) 215–222]
2018
·
Cândida Fonseca
, Aldo Pietro Maggioni
, et al.
·
International Journal of Cardiology
·
1
A closer look at acute heart failure: Putting Portuguese and European data into perspective
2016
·
Cândida Fonseca
, Inês Araújo
, et al.
·
Revista Portuguesa de Cardiologia (English Edition)
·
1
PDF
Patient journey mapping in polycythemia vera: an exploratory mixed-methods approach study to evaluate the quality of life in a cohort of Portuguese patients
2026
·
Francesca Pierdomenico
, Inês Costa
, et al.
·
RISE Health Research Journal
Physical impact and health-related quality of life of SCD in adults: the Real-World Portuguese ASCEND Study
2026
·
Christopher J Saunders
, Madalena Martins
, et al.
·
Journal of sickle cell disease.
Real-World Treatment Landscape and Dosing Patterns of CDK4/6 Inhibitors in HR+/HER2- Advanced/Metastatic Breast Cancer: Results from the PORTRAIT Study in Portugal
2026
·
Catarina Pulido
, Hugo Nunes
, et al.
·
SSRN Electronic Journal
CO207 Real-World Outcomes and Economic Impact of Ribociclib in HR+/HER2- Advanced Breast Cancer: Evidence From the Portuguese REASSURE Cohort
2025
·
Ana Sofia Patrão
, Maria José Bento
, et al.
·
Value in Health
Understanding stakeholders’ experience with sickle cell disease by social media listening across Europe
2025
·
Daniel Bras
, Celeste Bento
, et al.
·
Frontiers in Genetics
PDF
EE775 Treatment Cost for CDK 4/6 Inhibitors for HR+/HER2- Advanced and Metastatic Breast Cancer Patients in Portugal Based on Real-World Dosing Patterns: Insights From the PORTRAIT Study
2024
·
LV Costa
, C Pulido
, et al.
·
Value in Health
P121 Current treatment landscape from locally advanced to metastatic prostate cancer in Portugal: Preliminary results from the CAPTURE study
2024
·
M.A. Oliveira Rosinha
, C. Cardoso
, et al.
·
European Urology Open Science
410P Breast cancer lighthouse non-interventional hybrid real-world study: Molecular characterization and 2-year effectiveness data
2024
·
A.M. Nogal Dias
, A.L.V. Matos
, et al.
·
Annals of Oncology
PDF
451P Breast Cancer Lighthouse study: 1 year follow-up results of ribociclib treatment patterns and clinical outcomes in a real-world Portuguese cohort
2023
·
B.E. Gosalbez Pequeno
, A.L.V. Matos
, et al.
·
Annals of Oncology
PDF
Pb2510: Characterisation of Sickle Cell Disease Patients: a Portuguese Real-world Study (ascend)
2023
·
Maria Manuel Deveza
, Inês Nogueira Da Fonseca
, et al.
·
HemaSphere
5610614 Assessing Physical, Social and Emotional Impact of Sickle Cell Disease in Portuguese Patients: an Observational, Multicenter Study (ascend)
2023
·
C.S. Christopher Saunders
, M.M. Marinela Major
, et al.
·
HemaSphere
SA32 Adapting PROs Evaluation to COVID Context – The Case of ASCEND Study
2022
·
I Moital
, D Bras
, et al.
·
Value in Health
PDF
Neurohormonal modulation: The new paradigm of pharmacological treatment of heart failure
2019
·
J. Silva-Cardoso
, D. Brás
, et al.
·
Revista Portuguesa de Cardiologia (English Edition)
PDF
Errata a «Insuficiência Cardíaca em números: estimativas para o século XXI em Portugal»
2018
·
Cândida Fonseca
, Daniel Brás
, et al.
·
Revista Portuguesa de Cardiologia
PDF
Errata to “Heart failure in numbers: Estimates for the 21st century in Portugal”
2018
·
Cândida Fonseca
, Daniel Brás
, et al.
·
Revista Portuguesa de Cardiologia (English Edition)
PDF
Show more works
View as search
Works count:
25
Citation count:
168
H-index:
5
I10-index:
3
Year
Topic
Type